Péter Ferdinandy, MD, PhD, MBA, FESC, FISHR is listed in the global Highly Cited Researcher 2014, 2017, 2020, 2021, and 2022 databases acknowledging the world’s most influential scientists. He counts more than 300 papers and 5 patent families. His work is cited more than 20000 times and his Hirsh index is 73. He received an MD diploma in 1991 and a PhD in 1995 at the University of Szeged, Hungary. He became a registered clinical pharmacologist in 1999. He did his postdoctoral training at the Department of Pharmacology, University of Alberta, Edmonton, Canada. Then he finished an MBA course and got an MBA diploma in finance and quality management in 2004. He founded Pharmahungary Group, a group of R&D companies (www.pharmahungary.com) that have been involved in more than 300 drug/medical device development projects since their foundation in the early 2000s. Currently he is the vice-rector for science and innovations of the Semmelweis University, Budapest, Hungary (www.semmelweis.hu).
ESC 365 is supported by
